批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/11/26 |
SUPPL-51(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/08/18 |
SUPPL-50(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/09/20 |
SUPPL-47(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2021/02/06 |
SUPPL-45(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/01/04 |
SUPPL-38(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2014/07/18 |
SUPPL-35(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2012/12/18 |
SUPPL-31(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/04/10 |
SUPPL-32(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/07/08 |
SUPPL-30(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/07/08 |
SUPPL-22(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/03/21 |
SUPPL-33(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/03/21 |
SUPPL-29(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2011/03/21 |
SUPPL-26(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2010/10/27 |
SUPPL-27(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2009/08/07 |
SUPPL-23(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2009/01/30 |
SUPPL-25(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/10/31 |
SUPPL-24(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/08/02 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/08/22 |
SUPPL-19(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/08/22 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/02/06 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/02/06 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2001/11/08 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2001/04/30 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2001/04/30 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2001/02/15 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2000/09/28 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2000/09/21 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/07/18 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/06/27 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/02/23 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/02/20 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1997/11/06 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1997/06/25 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:PAROXETINE HYDROCHLORIDE 剂型/给药途径:SUSPENSION;ORAL 规格:EQ 10MG BASE/5ML 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020710 |
001 |
NDA |
PAXIL |
PAROXETINE HYDROCHLORIDE |
SUSPENSION;ORAL |
EQ 10MG BASE/5ML |
Discontinued |
Yes |
No |
AB |
1997/06/25
|
APOTEX |
215003 |
001 |
ANDA |
PAROXETINE HYDROCHLORIDE |
PAROXETINE HYDROCHLORIDE |
SUSPENSION;ORAL |
EQ 10MG BASE/5ML |
Prescription |
No |
Yes |
AB |
2021/09/03
|
NOVITIUM PHARMA |